Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects

Cardiovascular Research

Volumn 82, Issue 1, 2009, Pages 100-106

  Schmechel, Ariane ^a   Grimm, Michael ^a   El Armouche, Ali ^a   Höppner, Grit ^a   Schwoerer, Alexander P ^a   Ehmke, Heimo ^a   Eschenhagen, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

adrenergic signalling; Atorvastatin; Desensitization; G proteins; Heart; Isoprenaline

Indexed keywords

ATORVASTATIN; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; ISOPRENALINE; MESSENGER RNA; SODIUM CHLORIDE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; HEART; HEART ATRIUM CONTRACTILITY; HEART ATRIUM CONTRACTION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE FIBER MEMBRANE; HEART PERFUSION; HEART PROTECTION; HEART RATE; HEART WEIGHT; IMMOBILIZATION STRESS; INOTROPISM; ISOPRENYLATION; LOW DRUG DOSE; MALE; MINIPUMP; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELEMETRY; TISSUE HOMOGENATE; WISTAR RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELL MEMBRANE; CIRCADIAN RHYTHM; CYTOSOL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GTP-BINDING PROTEIN GAMMA SUBUNITS; HEART; HEART RATE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFUSION PUMPS, IMPLANTABLE; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTEIN TRANSPORT; PYRROLES; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 62349088989     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp005     Document Type: Article

References (29)

1. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and rennin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 1982;49:1659-1666.
2. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003;93:896- 906.
3. El-Armouche A, Zolk O, Rau T, Eschenhagen T. Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res 2003;60:478-487.
4. Bristow MR. beta-Adrenergic receptor blockade in chronic heart failure. Circulation 2000;101:558-569.
5. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008;14:37-44.
6. Muhlhauser U, Zolk O, Rau T, Munzel F, Wieland T, Eschenhagen T. Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. FASEB J 2006;20:785-787.
7. McDougall SJ, Paull JR, Widdop RE, Lawrence AJ. Restraint stress: differential cardiovascular responses in Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 2000;35:126-129.
8. El-Armouche A, Singh J, Naito H, Wittkopper K, Didie M, Laatsch A et al. Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue. J Mol Cell Cardiol 2007;43:371-376.
9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
10. Grimm M, Gsell S, Mittmann C, Nose M, Scholz H, Weil J et al. Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart. J Mol Cell Cardiol 1998;30:1917-1928.
11. Marsh JD, Barry WH, Smith TW. Desensitization to the inotropic effect of isoproterenol in cultured ventricular cells. J Pharmacol Exp Ther 1982;223:60-70.
12. Krause BR, Newton RS. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis 1995;117:237-244.
13. Kim S, Kim CH, Vaziri ND. Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy. Am J Physiol Endocrinol Metab 2005;288:E813-E817.
14. Cilla DD Jr, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Clin Pharmacol Ther 1996;60:687-695.
15. Stern RH, Yang BB, Hounslow NJ, MacMahon M, Abel RB, Olson SC. Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor. J Clin Pharmacol 2000;40:616-623.
16. Szramka M, Harriss L, Ninnio D, Windebank E, Brack J, Skiba M et al. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease. Int J Cardiol 2007;117:287-291.
17. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008;30:3-11.
18. Pliquett RU, Cornish KG, Peuler JD, Zucker IH. Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation 2003;107:2493-2498.
19. Welzig CM, Shin DG, Park HJ, Kim YJ, Saul JP, Galper JB. Lipid lowering by pravastatin increases parasympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness. Circulation 2003;108:2743-2746.
20. Albert PR, Robillard L. G protein specificity: traffic direction required. Cell Signal 2002;14:407-418.
21. Hansen CA, Schroering AG, Robishaw JD. Subunit expression of signal transducing G proteins in cardiac tissue: implications for phospholipase C-beta regulation. J Mol Cell Cardiol 1995;27:471-484.
22. Morishita R, Nakayama H, Isobe T, Matsuda T, Hashimoto Y, Okano T et al. Primary structure of a gamma subunit of G protein, gamma 12, and its phosphorylation by protein kinase C. J Biol Chem 1995;270:29469- 29475.
23. Cali JJ, Balcueva EA, Rybalkin I, Robishaw JD. Selective tissue distribution of G protein gamma subunits, including a new form of the gamma subunits identified by cDNA cloning. J Biol Chem 1992;267:24023- 24027.
24. Evanko DS, Thiyagarajan MM, Siderovski DP, Wedegaertner PB. Gbeta gamma isoforms selectively rescue plasma membrane localization and palmitoylation of mutant Galphas and Galphaq. J Biol Chem 2001;276:23945-23953.
25. Muntz KH, Sternweis PC, Gilman AG, Mumby SM. Influence of gamma subunit prenylation on association of guanine nucleotide-binding regulatory proteins with membranes. Mol Biol Cell 1992;3:49-61.
26. Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
27. Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 2006;100:323- 337.
28. Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006;47:332-337.
29. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007;357:2248-2261.